Mettler-Toledo International Inc (MTD)
Healthcare
Diagnostics & Research
1,416.30 $
+2.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Mettler-Toledo International Inc (MTD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 3,671 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3,289 | 3,356 | 3,283 | 3,249 | 3,320 | 3,240 | 3,235 | 3,400 | 3,521 | 3,713 | 3,669 | 3,671 | |
| 1,197 | 1,230 | 1,211 | 1,178 | 1,198 | 1,194 | 1,165 | 1,244 | 1,281 | 1,363 | 1,332 | 1,347 | |
| 70 | 70 | 70 | 71 | 72 | 59 | 64 | 62 | 69 | 67 | 61 | 51 | |
| 70 | 70 | 70 | 71 | 72 | 59 | 64 | 62 | 69 | 67 | 61 | 51 | |
| 635 | 664 | 650 | 635 | 637 | 687 | 638 | 682 | 687 | 778 | 708 | 731 | |
| 376 | 386 | 374 | 366 | 376 | 342 | 359 | 388 | 402 | 387 | 405 | 412 | |
| 763 | – | – | – | 790 | 770 | 778 | 817 | 818 | 846 | – | – | |
| 661 | 670 | 666 | 665 | 672 | 669 | 673 | 684 | 731 | 739 | 737 | 735 | |
| 287 | 285 | 274 | 268 | 263 | 257 | 252 | 254 | 278 | 279 | 274 | 266 | |
| 3,395 | 3,505 | 3,442 | 3,402 | 3,474 | 3,367 | 3,417 | 3,659 | 3,771 | 3,736 | 3,711 | 3,658 | |
| 1,070 | 1,181 | 1,132 | 1,281 | 1,185 | 1,168 | 1,150 | 1,107 | 1,192 | 1,198 | 1,108 | 1,201 | |
| 179 | 221 | 183 | 311 | 186 | 212 | 183 | 60 | 64 | 99 | 67 | 67 | |
| 174 | 210 | 189 | 199 | 203 | 216 | 201 | 216 | 247 | 267 | 229 | 230 | |
| 1,929 | 1,889 | 1,904 | 1,747 | 1,892 | 1,831 | 1,891 | 2,124 | 2,146 | 2,088 | 2,162 | – | |
| -106 | -150 | -159 | -153 | -154 | -127 | -182 | -259 | -249 | -24 | -42 | 13 | |
| 7,328 | 7,511 | 7,688 | 7,910 | 8,121 | 8,371 | 8,535 | 8,737 | 8,955 | 9,238 | 9,408 | 9,640 | |
| 22 | 22 | 22 | 21 | 21 | 21 | 21 | 21 | 21 | 20 | 20 | 20 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.